Jefferies Group LLC Ascendis Pharma A/S Put Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2019

Nov 13, 2019
SELL
$95.8 - $118.9 $4.31 Million - $5.35 Million
-45,000 Closed
0 $0
Q2 2019

Aug 14, 2019
BUY
$107.11 - $132.09 $2.41 Million - $2.97 Million
22,500 Added 100.0%
45,000 $5.18 Million
Q1 2019

May 15, 2019
BUY
$62.15 - $129.99 $1 Million - $2.09 Million
16,100 Added 251.56%
22,500 $2.65 Million
Q4 2018

Feb 14, 2019
BUY
$55.16 - $69.67 $353,024 - $445,888
6,400 New
6,400 $401,000

Others Institutions Holding ASND

# of Institutions
244
Shares Held
58.8M
Call Options Held
250K
Put Options Held
377K
View Full List

About Ascendis Pharma A/S

ASND Quotes by TradingView
  • Ticker ASND
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,810,200
  • Market Cap $7.61B
  • Description
  • Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...
More about ASND
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email